SCHEMBL4148343

SCHEMBL4148343

CN(C(=O)NCCOc1ccccc1)c1ccc(SC(F)(F)F)cc1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 1/20 0.43
MTNR1B P49286 1/20 0.43
HPGD P15428 2/20 0.42
ALDH1A1 P00352 1/20 0.42
NPC1 O15118 7/20 0.40
RAB9A P51151 7/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
RECQL P46063 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
POLB P06746 1/20 0.40
CASP3 P42574 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
KMT2A Q03164 4/20 0.40
MEN1 O00255 2/20 0.40
MAPT P10636 2/20 0.40
MAPK1 P28482 1/20 0.39
NTSR1 P30989 1/20 0.39
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
NOD2 Q9HC29 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5314000 0.86 MTNR1A (0.40) MTNR1AMTNR1BHPGDALDH1A1NPC1
SCHEMBL13774526 0.86 MCHR1 (0.37) HPGDALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL13774604 0.82 MTNR1A (0.48) MTNR1AMTNR1BHPGDALDH1A1NPC1
SCHEMBL4144739 0.82 MAPT (0.46) HPGDALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL4149965 0.82 ACKR3 (0.38) ALDH1A1SMN1; SMN2KMT2AMAPK1HTT
SCHEMBL4150001 0.81 MAPK1 (0.35) HPGDALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL4142022 0.80 PTPRZ1 (0.37) ALDH1A1SMN1; SMN2MAPTMAPK1HTT
SCHEMBL4144820 0.79 PTPRZ1 (0.35) SMN1; SMN2MAPTMAPK1HTTKDM4E
SCHEMBL4150851 0.79 PTPRZ1 (0.36) ALDH1A1L3MBTL1MAPTMAPK1HTT
SCHEMBL4145579 0.78 ROCK2 (0.48) HPGDALDH1A1SMN1; SMN2POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
EP-1937629-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-07-02 EP disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 MTNR1A 3541/4885MTNR1B 3670/4885HPGD 4852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.